English|China's First Oral Drug for COVID-19 Approved English

文章图片

Image Source: Visual China
BEIJING, July 16 (TMTPOST) – Genuine Biotech has received emergency conditional approval for its Azvudine tablets from China’s National Medical products Association (NMPA) for the treatment of adult patients suffering moderate Covid-19.
For a seven-day treatment of Azvudine, which is also used for treating HIV, the total charge is 910 yuan (about US$134). Paxlovid, the only rival of Azvudine in the Chinese market, would cost a patient 2,300 yuan (about US$340).
Shortly after the approval of the drug, Fosun Pharmaceutical, owned by Chinese billionaire Guo Guangchang, announced that it had reached an exclusive strategic partnership with Genuine Biotech on developing and commercializing Azvudine tablets.
Developed initially as a treatment for HIV, Genuine Biotech’s Azvudine tablets also obtained conditional approvals from the NMPA on July 20, 2021 for use in the treatment of HIV in adults in July last year.
Azvudine reported that 40% of people that took the Azvudine improved their COVID symptoms within seven days of taking the drug while, in the control group of unmedicated patients, just 10% of COVID symptoms improved, according to the Genuine Biotech's report.
“Covid-19 continues to mutate, causing pandemic resurgence across the globe. Vaccines and drug treatments remain to be powerful weapons for humans to combat viruses,” Fosun Pharmaceutical’s CEO Wen Deyong said. “Azvudine tablet is the first Covid-19 drug taken by mouth developed by a Chinese company with the approval from the authorities. We believe the recent development will help control and curb the pandemic. We are happy to reach a strategic partnership with Genuine Biotech and hope to develop treatments and prevention solutions for Covid-19.”
【English|China's First Oral Drug for COVID-19 Approved】“We will make use of Fosun Pharmaceutical’s innovation and commercialization capabilities accumulated over years and utilize the advantages from out international operation to bring Azvudine tablets to patients around the world,” Wen said.

English|China's First Oral Drug for COVID-19 Approved

推荐阅读

如何用sql实现事务 ssmmysql事物

白带酸腥味怎么回事？

广州海珠区公租房轮候申请需要哪些条件

Vue.js之render函数使用详解

下跌中继，继续寻底下跌中继

毛巾发腻如何处理

mongodb升序 mongodb 降级

太原独特壹家装饰公司怎么样太原独特壹家装饰公司怎么样呀

IOS证书是什么，iPhone开发为什么一定要证书这个证书在我们开发直至发布应用的过

线性回归的matlab分析论文,spss多元线性回归分析论文

什么地放开

python主函数位置 python在主函数中调用函数

运动会项目有哪些

如何判断子宫脱垂程度如何判断子宫脱垂，如何判断子宫脱垂几度

vivo手机没有语音唤醒怎么办

日立空调遥控器显示日立空调空调遥控器图标是什么意思

七一表彰个人主要事迹七一勋章获得者

红烧茄子下锅炸多久才熟红烧茄子下锅炸多久才熟透

口罩洗了还能用吗

法律援助予以受理的条件，法律援助予以受理的条件是